Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book highlights the genomic findings, observations, and analysis of DNA/RNA sequences and protein structure of the dreadful virus of this decade- COVID-19. The Corona group of viruses though known species, the strain that caused the Pandemic of 2019 is a completely new strain, belonging to the same corona family with a novel genetic make-up. This makes it a new pathogen which is causing the current outbreak leaving the global scientific community clueless of any therapeutic breakthrough. NCOV enjoys life threatening pathogenicity with mysterious genetic annotations. This book details and…mehr
This book highlights the genomic findings, observations, and analysis of DNA/RNA sequences and protein structure of the dreadful virus of this decade- COVID-19. The Corona group of viruses though known species, the strain that caused the Pandemic of 2019 is a completely new strain, belonging to the same corona family with a novel genetic make-up. This makes it a new pathogen which is causing the current outbreak leaving the global scientific community clueless of any therapeutic breakthrough. NCOV enjoys life threatening pathogenicity with mysterious genetic annotations. This book details and offers insights into its viral genetic arrangement, Virulence factors, probable mutations leading to the evolution of this new strain and more. It contains chapters on Virus evolutionary status and Genetic makeup leading to its pathogenicity which can be a new insight in understanding the nature of this clever microorganism and can pave way to the development of new drugs and Vaccinesor a novel diagnostic approach for the early prognosis of the disease. A dedicated chapter on annotation of NCOV-19 virulence genes, translation of the genes to protein product, annotation of the antigenic sites on these proteins is also included. In all, this brief is a complete genomic annotation insight of NCOV-19 using AI, Data analytics and Bioinformatics analysis. In the current situation, this book is an extensive preliminary resource for Medical practitioners, Researchers, Academicians, Scientists, Biochemists, Bioinformaticians and other professionals interested in understanding the genetics of Novel Coronavirus 19, the best possible drug targets, ideal vaccine candidates and novel prognostic and diagnostic biomarkers.
Amit is DNA Forensics Professional, Entrepreneur, Engineer, Bioinformatician and an IEEE Volunteer. In 2005 he founded first Private DNA Testing Company Bio Axis DNA Research Centre (P) Ltd in Hyderabad, India with an US Collaborator. He has vast experience of training 1000+ Crime investigation officers and helped 750+ Criminal and non-criminal cases to reach justice by offering analytical services in his laboratory. His group also works extensively on Genetic Predisposition risk studies of cancers and has been helping many cancer patients from 2012 to fight and win the battle against cancer. Amit was member of IEEE Strategy Development and Environmental Assessment committee (SDEA) of IEEE MGA. He is senior member of IEEE and has been a very active IEEE Volunteer at Section, Council, Region, Technical Societies of Computational Intelligence and Engineering in Medicine and Biology and at IEEE MGA levels in several capacities. He has driven a number of IEEE Conferences, Conference leadership programs, Entrepreneurship development workshops, Innovation and Internship related events. Currently He is the Managing Director of BioAxis DNA Research Centre (P) Ltd and visiting Professor at SJB Research Foundation, IEEE MGA Nominations and Appointments committee member and Chairman of IEEE Hyderabad Section.
Prof. Ajit K. Saxena has received his Ph.D. from Department of Anatomy in Cyotgenetics from Institute of Medical Sciences, B.H.U. in the year of 1990. During his Ph.D. he studied how anticancer drugs cause interference with normal development of the foetus and with special reference to the cause of abnormality during differentiation of male gonads which lead infertility including congenital anomalies. After receiving his Ph.D. degree he joined NIH funded Indo US project at AIIMS New Delhi; where he identified the role of novel antigen IL6 as a signal traducing agent in human glioblastoma. He also worked in various renowned Institutions of India and abroad including C.C.M.B., C.D.R.I., A.M.C., B.P.K.I.H.S. (Dharan, Nepal) and B.H.U.,Varanasi. Currently, he is working as a Professor and Head in the Department of Pathology/Lab Medicine specialized in Clinical Genetics in All India Institute of Medical Sciences, Patna. He also possess administrative responsibilities as Head of the Department in prestigious institutions of India & abroad. In addition he has also served his duties of Scientific Advisor to the Government. His research interest includes study of Gene Polymorphism in Congenital Neural Tube Defects/ Tumor Biology/Infertility and Cytokines gene expression in chronic wounds and hypertrophic scars. Currently, his research interest includes role of stem cells in translational research. Of course, Dr Saxena published more than 100 articles in peer reviewed journals of international reputes with high citations. Based on his research and fellowship training, he has received several Awards and Honours, such as Gold Medal Award, Confer ‘Vivek Ratan Award’ and Millennium Award, Health Care Excellence Award, Life Time Achievement Awards (three times). Besides his research, teaching and administration he has also guided postgraduate (Ph.D,MD,MS, MTech) students. He is serving as an editorial member of various reputed journals and reviewer for several government funded project and research papers. He also acquired and completed several Government funded research projects (ICMR, DBT, CSIR,DST). Dr Saxena is a “fellow” and “member” of various scientific organizations, National Academy of Sciences, USA, National Academy for advancement of science and technology (USA), member of National Academy of Medical Sciences, India. He is also a Fellow of Indian Association of Biomedical Scientist, Chennai, Fellow of Indian Association of Applied Biotechnology, Mysore. Currently he is engaged in the developing Advanced Clinical Genetics Laboratory for Diagnostic, Training and Research in India (Bihar).
Chris Gwo Giun Lee is an investigator in signal processing systems for multimedia and bioinformatics. His work on analytics of algorithm concurrently with architecture, Algorithm/Architecture Co-Design (AAC), has made possible accurate and efficient computations on SoC, cloud, and edge. His work has contributed to 130+ publications with the invention of 50+ patents globally. His AAC work resulted in industry deployment of 60+ million LCD panels worldwide. Two patents were licensed by the US health industry for the development of analytics platform based precision medicine products (Boston, MA, June 1, 2015, GLOBE NEWSWIRE). His work was pivotal in delivering international standards, e.g. and RVC & 3D HEVC in MPEG. Chris was a system architect in Philips Semiconductor, project leader in Silicon Valley, and was recruited to NCKU in 2003. He received BSEE from NTU, Taiwan, MSEE, and PHDEE from UMASS. Chris is AE for IEEE TSP and was AE for IEEE TCSVT and received Best AE Award in 2011. and received the Best AE Award in2011.
Amita Kashyap is CEO of BioAxis DNA Research Centre (P) Ltd, First Private Indian DNA testing Company. She has wide experience of handling various corporate R&D and service based Projects related to Molecular Biology, DNA Fingerprinting and Bioinformatics. Amita has offered services as Scientific expert in Indian Courts and was with BDRC Team in 2008 when the company delivered DNA Based Evidence collection training to Andhra Pradesh Police in various DTCs and PTCs Andhra Pradesh, Orissa Crime Branch and Bihar Forensic Science Laboratory. Her work on Forensic Bioinformatics was awarded Gold Medal at Indian institute of Toxicology Research, Council of Scientific and Industrial Research, Lucknow. She has wide experience in handling Government funded projects, has been Principal Investigator of a DST Funded Project on Non Small Cell Lung Cancer and the Ras Proto-Oncogene, Completed at CRRAO AIMSCS, University of Hyderabad Campus and Currently CoPI of Feature Extraction fromMedical Images Related to Tuberculosis Bacilli and Study of ADR on Quality of TB Patient Life Undergoing Short Course Observed Treatment funded by Department of Science and Technology, Government of India.
Mrs. G Jyothsna was a gold medallist for the Academic year 2010 from Kakatiya University, Warangal. Presently she is Senior Research Associate with BioAxis DNA research Centre Pvt Ltd Hyderabad and is involved in handling the Biotechnology and Bioinformatics Research projects of Organisation. Mrs Jyothsna has organised several Conferences and Workshops in the field of Bioinformatics and Biotechnology in collaboration with number of Universities and Research Organisations. She has more than 30 International Publications. She has guided 500+ students in successful completion of their academic Projects. Jyothsna is also one of the active members in a DST Sponsored IRHPA project on Type 2 Diabetes. Her areas of Research include Mutational Studies and Protein Analysis.
Inhaltsangabe
1. COVID19 and The Novel Corona Virus 2019.- 2. The Genomic and Evolutionary Studies of Novel Corona Virus 2019.- 3. Comparative proteomic analysis of NCoV and MERS Corona Virus.- 4. Physiochemical Characterization and Domain annotation of ORF1ab polyprotein of Novel Corona Virus 19.- 5. Docking studies of the RNA dependent RNA polymerase domain of ORF1AB protein with the selected ligands of Novel Coronavirus 19.- 6. Noted Herbs in the Treatment of COVID19 and Improving Human Immunity.- 7. Architecture of COVID-19 and SARS CoV-spike structural and functional aspects with ACE2 receptor: In-Silico analysis.- 8. Plasma Therapy towards COVID treatment.- 9. Identification and analysis of Possible Vaccine Candidates for COVID19.- 10. Development of KITS for Rapid Diagnosis of COVID19
1. COVID19 and The Novel Corona Virus 2019.- 2. The Genomic and Evolutionary Studies of Novel Corona Virus 2019.- 3. Comparative proteomic analysis of NCoV and MERS Corona Virus.- 4. Physiochemical Characterization and Domain annotation of ORF1ab polyprotein of Novel Corona Virus 19.- 5. Docking studies of the RNA dependent RNA polymerase domain of ORF1AB protein with the selected ligands of Novel Coronavirus 19.- 6. Noted Herbs in the Treatment of COVID19 and Improving Human Immunity.- 7. Architecture of COVID-19 and SARS CoV-spike structural and functional aspects with ACE2 receptor: In-Silico analysis.- 8. Plasma Therapy towards COVID treatment.- 9. Identification and analysis of Possible Vaccine Candidates for COVID19.- 10. Development of KITS for Rapid Diagnosis of COVID19
1. COVID19 and The Novel Corona Virus 2019.- 2. The Genomic and Evolutionary Studies of Novel Corona Virus 2019.- 3. Comparative proteomic analysis of NCoV and MERS Corona Virus.- 4. Physiochemical Characterization and Domain annotation of ORF1ab polyprotein of Novel Corona Virus 19.- 5. Docking studies of the RNA dependent RNA polymerase domain of ORF1AB protein with the selected ligands of Novel Coronavirus 19.- 6. Noted Herbs in the Treatment of COVID19 and Improving Human Immunity.- 7. Architecture of COVID-19 and SARS CoV-spike structural and functional aspects with ACE2 receptor: In-Silico analysis.- 8. Plasma Therapy towards COVID treatment.- 9. Identification and analysis of Possible Vaccine Candidates for COVID19.- 10. Development of KITS for Rapid Diagnosis of COVID19
1. COVID19 and The Novel Corona Virus 2019.- 2. The Genomic and Evolutionary Studies of Novel Corona Virus 2019.- 3. Comparative proteomic analysis of NCoV and MERS Corona Virus.- 4. Physiochemical Characterization and Domain annotation of ORF1ab polyprotein of Novel Corona Virus 19.- 5. Docking studies of the RNA dependent RNA polymerase domain of ORF1AB protein with the selected ligands of Novel Coronavirus 19.- 6. Noted Herbs in the Treatment of COVID19 and Improving Human Immunity.- 7. Architecture of COVID-19 and SARS CoV-spike structural and functional aspects with ACE2 receptor: In-Silico analysis.- 8. Plasma Therapy towards COVID treatment.- 9. Identification and analysis of Possible Vaccine Candidates for COVID19.- 10. Development of KITS for Rapid Diagnosis of COVID19
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309